from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3820c/papA2

LFCtreatmentdescriptionclass of inhibitor

-0.007

Amikacinug/mL Amikacintranslation

1.569

Cap5-10ug/mL Capreomycintranslation

1.358

Rox10-50 ug/mL Roxithromycintranslation

0.030

SM2-5 ug/mL Streptomycintranslation

0.266

Tet5-10 ug/mL Tetracyclinetranslation

-1.016

Rif0.2-5ug/mL Rifampicintranscription

-0.515

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.844

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.188

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.313

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.929

Clofazimine10-13 ug/mL Clofaziminerespiration

0.168

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.383

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.275

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.286

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.031

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.251

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.198

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.249

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.733

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.564

KCN5-20 ug/mL Potassium cyaniderespiration

-0.748

NaN30.2-2 mM Sodium aziderespiration

0.825

Nigericin50 uM Nigericinrespiration

-1.012

TRC10-150 ug/mL Triclosanrespiration

-1.366

TRZ10-25 ug/mL Thioridazinerespiration

0.500

Valinomycin0.5-10 uM Valinomycinrespiration

2.047

ZnSO42 mM ZnSO4respiration

0.293

menadione6-10 ug/mL Menadionerespiration

0.147

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.687

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.154

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.201

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.263

NRP_1Non-replicating persistence stage 1dosRassociated

0.373

Amp0.2mg/mL AmpicillincellWall

0.074

Cephalexin20-100 ug/mL CephalexincellWall

0.743

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.105

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.251

EMB10-20 ug/mL EthambutolcellWall

-0.107

Eta12-40 ug/mL EthionamidecellWall

-0.266

INH0.2-0.4 ug/mL IsoniazidcellWall

0.053

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.346

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.006

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.053

BZA0.12 mg/mL BenzamidearomaticAmides

0.175

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.125

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.427

H2O24 mM hydrogen peroxideDNAdamaging

0.528

Levo10 ug/mL LevofloxacinDNAdamaging

0.739

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.431

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.505

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.492

UVUV-irradiationDNAdamaging

-0.056

ARP41-4 ug/mL Antitubercular compound ARP4?

0.662

Antimycin12.5-50 ug/mL Antimycin A?

0.633

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.023

PA_110-50 ug/mL Antitubercular compound PA-1?

0.411

PA_2110-50 ug/mL Antitubercular compound PA-21?

-2.021

PA8240.2-2 ug/mL PA-824?

-1.551

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.698

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.538

Verapamil50 uM Verapamil?

0.179

mercaptoethanol2 mM 2-Mercaptoethanol?

1.072

methoxatin10-20 ug/mL Methoxatin?